Other Search Results
DatChat, Inc. Announces Proposed Underwritten Public Offering of Common Stock - GlobeNewswire

New Brunswick, NJ, Jan. 16, 2024 (GLOBE NEWSWIRE) -- DatChat, Inc. (Nasdaq: DATS) (“Datchat” or the “Company”) , a secure messaging, social media, and metaverse company, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actu...

Public offering - definition of public offering by The Free Dictionary

Define public offering. public offering synonyms, public offering pronunciation, public offering translation, English dictionary definition of public offering. n. See initial public offering. Ameri...

NioCorp Announces Pricing of Approximately $6.0 Million Underwritten Public Offering & Concurrent Private....

CENTENNIAL, CO / ACCESSWIRE / November 3, 2024 / NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:NB) today announced the pricing of its previously announced underwritten public offering in the United States (the " Registered Offering") and concurrent private placement (the "Private Offering" and, together with the Registered Offering, the "Offerings"). The Registered Offering consists of 1,592,356 common shares, 1,592,356 Series A warrants to purchase up to an additional 1,592,356...

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stoc - GlobeNewswire

BURLINGTON, Mass., Aug. 12, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced a proposed underwritten public offering of shares (“Shares”) of its common stock or, in lieu of Shares, pre-funded warrants (the “Pre-Funded Warrants”) to purchase Shares (the “Offering”). scPharmaceuticals also ...

PolyPid Announces Proposed Underwritten Public Offering of Ordinary Shares | Polypid

March 28, 2023 at 4:05 PM EDT ; PETACH TIKVA, Israel, March 28, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, announced today that it has commenced an underwritten public offering of its ordinary shares, no par value (the “Ordinary Shares”). In addition, PolyPid intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the number of Ordinary Shares of...

GreenPower Announces Closing of US$2.3 Million Underwritten Public Offering - PR Newswire

announced underwritten public offering (the "Offering"). The Offering consisted of 1,500,000 common shares and warrants to purchase 1,500,000 common shares. Each common share was sold...

Nuwellis Announces Pricing of $9.6 Million Upsized Underwritten Public Offering

an underwritten public offering of units for gross proceeds of approximately $9.6 million prior to deducting underwriting discounts and commissions and offering expenses payable by...

Crown Electrokinetics Prices Underwritten Public Offering of Common Stock

(NASDAQ: CRKN) ("Crown" or the "Company"), a leading smart glass technology company, today announced the pricing of an underwritten public offering of 1,250,000 shares of its common stock...

CleanSpark Announces Proposed Underwritten Public Offering of Common Stock | CLSK Stock News

CleanSpark, Inc. (Nasdaq: CLSK) announced plans for an underwritten public offering of its common stock, subject to market conditions. H.C. Wainwright & Co. will serve as the sole book-running mana...

Draganfly Announces Pricing of US$3.6 Million Underwritten Public Offering - GlobeNewswire

Saskatoon, SK., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 13,400,000 units, with each unit consisting of one common share (or one pre-funded warrant to purchase one common share in lieu thereof) and one warrant to purchase one common share. Each unit was sold at a public offering price of US$0.27, for gross proc ...

Copyright © www.babybloodtype.com. All rights reserved.
policy sang_list